ADR Biomedical Holdings Inc. (TYO:3750)
Japan flag Japan · Delayed Price · Currency is JPY
771.00
-6.00 (-0.77%)
Nov 18, 2026, 9:57 AM JST

ADR Biomedical Holdings Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
721252551,0381,123851
Cash & Short-Term Investments
721252551,0381,123851
Cash Growth
-75.17%-50.98%-75.43%-7.57%31.96%-20.39%
Accounts Receivable
4-126258113117
Other Receivables
-181----
Receivables
455258113117
Inventory
7566441031161,646
Prepaid Expenses
6478----
Other Current Assets
392621622836415
Total Current Assets
2543505171,4271,3883,029
Property, Plant & Equipment
--2,9604,21711,72712,041
Long-Term Investments
171758149130194
Goodwill
----647693
Other Intangible Assets
--2214149
Long-Term Deferred Tax Assets
----157-
Other Long-Term Assets
11-21-
Total Assets
2723683,5375,81614,09116,006

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
21----
Accrued Expenses
2924----
Short-Term Debt
370-30070500164
Current Portion of Long-Term Debt
--5454401553
Current Income Taxes Payable
1165----
Other Current Liabilities
6136137412272278
Total Current Liabilities
4632264915361,173995
Long-Term Debt
--2,2932,3477,6058,550
Pension & Post-Retirement Benefits
1211----
Long-Term Deferred Tax Liabilities
-1071101251,4361,517
Other Long-Term Liabilities
-1213141,2211,229
Total Liabilities
4743462,9073,02211,43512,291

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
100100100100100100
Additional Paid-In Capital
2,9392,9392,9392,9392,9392,939
Retained Earnings
-3,240-3,015-2,618-458-596462
Treasury Stock
-1-1-1-1-1-
Comprehensive Income & Other
--1210210210211
Total Common Equity
-202226302,7902,6523,712
Minority Interest
---443
Shareholders' Equity
-202226302,7942,6563,715
Total Liabilities & Equity
2723683,5375,81614,09116,006

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
370-2,6472,4718,5069,267
Net Cash (Debt)
-298125-2,392-1,433-7,383-8,416
Net Cash Growth
------
Net Cash Per Share
-33.3814.00-267.91-159.95-826.90-953.13
Filing Date Shares Outstanding
8.938.938.938.938.938.93
Total Common Shares Outstanding
8.938.938.938.938.938.93
Working Capital
-209124268912152,034
Book Value Per Share
-22.632.4670.56312.49297.03415.74
Tangible Book Value
-202226282,7691,9642,970
Tangible Book Value Per Share
-22.632.4670.34310.14219.97332.63